Pfizer’s reportedly reached an agreement to purchase Medivation—a biotech firm known for its prostate-cancer drug Xtandi—in what’s anticipated to be a $14 billion deal – WSJ and Bloomberg
Valeant’s hiring Zoetis’ Paul Herendeen as its new CFO as part of a continued effort to get back on track under the watchful eye of Bill Ackman – WSJ and NYTimes
So here’s a little reversal of our normal M&A story: Lyft wants someone to buy it [hey GM, hint, hint], but no one’s taking the bait – NYTimes
Buckle up folks, because the Fed’s doing its part to signal markets that a 2016 rate hike is definitely on the table – Bloomberg and Marketwatch
Rent-to-own homes are the latest attempt to open the housing market to the typically subprime set, and their “as is” status has left more than a few tenants holding the bag for major repairs – NYTimes
JPMorgan is set to receive a $645 million payout from the FDIC to resolve indemnification claims concerning JPM’s 2008 purchase of WaMu – Law360
The SEC’s opened an inquiry into Hampton Creek in response to a Bloomberg report that the Just Mayo maker used undercover contractors to purchase its non-egg mayonnaise product in bulk not long before HC raised $90 million from VCs and other private investors – NYTimes
Bank debt as a security? That’s part of the dicta in a bankruptcy court holding in the General Motors preference litigation that could have wide-reaching effects in the industry. Some [slightly insider] analysis here – Law360
ChemChina’s $43 billion bid to acquire Syngenta has received an official stamp of approval [or at least, acquiescence] from US regulators – NYTimes and WSJ
Here’s a pretty nifty recap of the just-closed Rio games, including a certain current that seemed to run through just about all of its top stories – NYTimes
Shinzo as Mario didn’t make it, by the way. But it definitely merits its own entry – WSJ